Susceptibility of Mink (Mustera vision)-Derived Cells to Replication by Human Immunodeficiency Virus Type 1
暂无分享,去创建一个
[1] S. Matsushita,et al. Ability of small animal cells to support the postintegration phase of human immunodeficiency virus type-1 replication. , 2003, Virology.
[2] C. Cheng‐Mayer,et al. Addition of a Single gp120 Glycan Confers Increased Binding to Dendritic Cell-Specific ICAM-3-Grabbing Nonintegrin and Neutralization Escape to Human Immunodeficiency Virus Type 1 , 2002, Journal of Virology.
[3] M. Goldsmith,et al. Progress Toward a Human CD4/CCR5 Transgenic Rat Model for De Novo Infection by Human Immunodeficiency Virus Type 1 , 2002, The Journal of experimental medicine.
[4] T. Greenough,et al. CD4 Down-Modulation by Human Immunodeficiency Virus Type 1 Nef Correlates with the Efficiency of Viral Replication and with CD4+ T-Cell Depletion in Human Lymphoid Tissue Ex Vivo , 2001, Journal of Virology.
[5] M. Goldsmith,et al. Susceptibility of Rat-Derived Cells to Replication by Human Immunodeficiency Virus Type 1 , 2001, Journal of Virology.
[6] H. Kräusslich,et al. Mouse-Human Heterokaryons Support Efficient Human Immunodeficiency Virus Type 1 Assembly , 2001, Journal of Virology.
[7] 田原 聡子. Differential level in co-down-modulation of CD4 and CXCR4 primed by HIV-1 gp120 in response to phorbol ester, PMA, among HIV-1 isolates , 2001 .
[8] B. Cullen,et al. Multiple Blocks to Human Immunodeficiency Virus Type 1 Replication in Rodent Cells , 2000, Journal of Virology.
[9] A. Fauci,et al. Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis , 2000, Immunological reviews.
[10] H. Nakauchi,et al. Differential Level in Co‐Down‐Modulation of CD4 and CXCR4 Primed by HIV‐1 gp120 in Response to Phorbol Ester, PMA, among HIV‐1 Isolates , 2000, Microbiology and immunology.
[11] T. Hope,et al. A Block to Human Immunodeficiency Virus Type 1 Assembly in Murine Cells , 2000, Journal of Virology.
[12] B. Cullen,et al. Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein , 1999, Current Biology.
[13] D. Trono,et al. Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner , 1999, Current Biology.
[14] O. Nishimura,et al. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[15] R. Gaynor,et al. Role of the human and murine cyclin T proteins in regulating HIV-1 tat-activation. , 1999, Journal of molecular biology.
[16] J. Albert,et al. Primary Human Immunodeficiency Virus Type 2 (HIV-2) Isolates, Like HIV-1 Isolates, Frequently Use CCR5 but Show Promiscuity in Coreceptor Usage , 1999, Journal of Virology.
[17] B. Peterlin,et al. Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. Farber,et al. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.
[19] B. Cullen,et al. Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV‐1 Tat , 1998, The EMBO journal.
[20] M. Garber,et al. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. , 1998, Genes & development.
[21] M. L. Penn,et al. Rabbit Cells Expressing Human CD4 and Human CCR5 Are Highly Permissive for Human Immunodeficiency Virus Type 1 Infection , 1998, Journal of Virology.
[22] G. Suzuki,et al. Disturbed CD4+ T Cell Homeostasis and In Vitro HIV-1 Susceptibility in Transgenic Mice Expressing T Cell Line–tropic HIV-1 Receptors , 1998, The Journal of experimental medicine.
[23] Ping Wei,et al. A Novel CDK9-Associated C-Type Cyclin Interacts Directly with HIV-1 Tat and Mediates Its High-Affinity, Loop-Specific Binding to TAR RNA , 1998, Cell.
[24] C. Raker,et al. Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[25] M. Mathews,et al. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. , 1997, Genes & development.
[26] D. Hazuda,et al. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. , 1997, Genes & development.
[27] A. Trkola,et al. Co-receptors for HIV-1 entry. , 1997, Current opinion in immunology.
[28] P. Kimmel,et al. Human chromosome 6- and 11-encoded factors support human immunodeficiency virus type 1 Rev function in A9 cells , 1996, Journal of virology.
[29] M. Mehtali,et al. Human immunodeficiency virus type 1 infection of human CD4-transgenic rabbits. , 1995, The Journal of general virology.
[30] R. Connor,et al. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. , 1995, Virology.
[31] C. Cheng‐Mayer,et al. HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. , 1994, Immunity.
[32] Yamamura Ken-ichi,et al. Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .
[33] H. Niwa,et al. Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.
[34] M. Malim,et al. Mutational definition of the human immunodeficiency virus type 1 Rev activation domain , 1991, Journal of virology.
[35] S. Sell,et al. Syphilis superinfection activates expression of human immunodeficiency virus I in latently infected rabbits. , 1991, The American journal of pathology.
[36] D. Baltimore,et al. A human cell factor is essential for HIV‐1 Rev action. , 1990, The EMBO journal.
[37] L. Bacheler,et al. Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells. , 1989, Science.
[38] G. Filice,et al. Infection of rabbits with human immunodeficiency virus , 1988, Nature.
[39] M. Yaniv,et al. Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma , 1984, Cell.